Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.43 |
| ▸ | CES1 | P23141 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | GRB2 | P62993 | 1/20 | 0.35 |
| ▸ | DAO | P14920 | 2/20 | 0.34 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.32 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | KCNN4 | O15554 | 3/20 | 0.31 |
| ▸ | KMO | O15229 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8880417 | 0.83 | CES2 (0.43) | CES2CES1ALDH1A1DAOBCHE | |
| SCHEMBL6525908 | 0.82 | CES2 (0.42) | CES2CES1ALDH1A1BCHERIPK1 | |
| SCHEMBL29009844 | 0.80 | CES2 (0.41) | CES2CES1ALDH1A1DAOAR | |
| SCHEMBL27176550 | 0.78 | MEP1B (0.40) | CES2CES1ALDH1A1ARKDM4E | |
| SCHEMBL4946196 | 0.78 | CES2 (0.33) | CES2CES1ALDH1A1 | |
| SCHEMBL2974322 | 0.78 | CES2 (0.39) | CES2CES1KIF11 | |
| SCHEMBL10608232 | 0.77 | CES1 (0.38) | CES2CES1ALDH1A1DAOHPGD | |
| SCHEMBL206670 | 0.75 | CES2 (0.41) | CES2CES1BCHEKIF11 | |
| SCHEMBL30628198 | 0.75 | KMO (0.41) | ALDH1A1KMT2AKMO | |
| SCHEMBL6057597 | 0.75 | SLC22A12 (0.39) | CES1ALDH1A1GRB2HPGDKCNN4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120199973-A | Polyvinylidene fluoride composite diaphragm for zinc battery and preparation method and application thereof | 中国科学院赣江创新研究院 | 2025-06-24 | — | — | CN | claimed |
| WO-2022163846-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | 第一三共株式会社 | 2022-08-04 | — | — | WO | claimed |
| CN-120199973-A | Polyvinylidene fluoride composite diaphragm for zinc battery and preparation method and application thereof | 中国科学院赣江创新研究院 | 2025-06-24 | — | — | CN | disclosed |
| US-11684584-B2 | Branched peg molecules and related compositions and methods | GENEVANT SCIENCES GMBH (CH) | 2023-06-27 | — | — | US | disclosed |
| WO-2022163846-A1 | NOVEL METHOD FOR PRODUCING ANTIBODY-IMMUNOSTIMULATOR CONJUGATE | 第一三共株式会社 | 2022-08-04 | — | — | WO | disclosed |
| EP-1157003-A1 | ACYLATED AMINOACETONITRILES AS CYSTEINE PROTEASE INHIBITORS | AstraZeneca AB (SE) | 2001-11-28 | — | — | EP | disclosed |
| WO-2000048992-A1 | ACYLATED AMINOACETONITRILES AS CYSTEINE PROTEASE INHIBITORS | ASTRAZENECA AB (SE) | 2000-08-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11684584-B2 | Branched peg molecules and related compositions and methods | CLTB, EGFR, HDGF | CES2 1645/4885CES1 1313/4885ALDH1A1 4274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.